SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Income Statement
Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q4 23), "Revenue" came in at 308 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 52 | 115 | 327 | 327 | 10,981 | 8,394 | 1,212 | 280 | 1,682 | 140 | 308 | |
| 2.0 | 7.6 | 14 | 44 | 44 | 632 | 440 | 254 | 430 | 1,304 | 188 | – | |
| 13 | 45 | 101 | 284 | 284 | 10,349 | 7,953 | 958 | -150 | 378 | -48 | 308 | |
| 5.7 | 14 | 26 | 2.7 | 2.7 | 54 | 101 | 184 | 258 | 399 | 151 | 193 | |
| 17 | 31 | 47 | 83 | – | – | – | – | – | – | – | – | |
| 22 | 45 | 74 | 87 | 87 | 216 | 533 | 341 | 929 | 1,069 | 383 | 370 | |
| -8.8 | -0.2 | 28 | 197 | 197 | 10,133 | 7,420 | 617 | -1,078 | -202 | -431 | -123 | |
| 0.2 | 0.4 | 0.5 | 0.3 | 0.3 | 1.5 | 1.3 | 0.6 | 0.6 | 2.5 | 0.3 | 2.0 | |
| -8.5 | -0.1 | 27 | 198 | 198 | 6,678 | 4,893 | 620 | -570 | -200 | -17 | -89 | |
| -1.1 | 1.2 | 5.7 | 26 | 26 | 1,570 | 1,534 | 136 | -199 | -115 | -34 | 139 | |
| -5.9 | -3.8 | 11 | 173 | 109 | 5,108 | 3,359 | 485 | -371 | -85 | 17 | -117 | |
| -7.4 | 1.9 | 28 | 200 | 200 | 10,150 | 7,471 | 695 | -822 | -207 | 21 | -27 |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.